Abstract
Recent studies indicate that chronic sleep restriction can have negative consequences for brain function and peripheral physiology and can contribute to the allostatic load throughout the body. Interestingly, few studies have examined how the sleep–wake system itself responds to repeated sleep restriction. In this study, rats were subjected to a sleep-restriction protocol consisting of 20 h of sleep deprivation (SD) followed by a 4-h sleep opportunity each day for 5 consecutive days. In response to the first 20-h SD block on day 1, animals responded during the 4-h sleep opportunity with enhanced sleep intensity [i.e., nonrapid eye movement (NREM) delta power] and increased rapid eye movement sleep time compared with baseline. This sleep pattern is indicative of a homeostatic response to acute sleep loss. Remarkably, after the 20-h SD blocks on days 2–5, animals failed to exhibit a compensatory NREM delta power response during the 4-h sleep opportunities and failed to increase NREM and rapid eye movement sleep times, despite accumulating a sleep debt each consecutive day. After losing ≈35 h of sleep over 5 days of sleep restriction, animals regained virtually none of their lost sleep, even during a full 3-day recovery period. These data demonstrate that the compensatory/homeostatic sleep response to acute SD does not generalize to conditions of chronic partial sleep loss. We propose that the change in sleep–wake regulation in the context of repeated sleep restriction reflects an allostatic process, and that the allostatic load produced by SD has direct effects on the sleep–wake regulatory system.
Keywords: allostasis, homeostasis, sleep deprivation, stress, rodents
A long-standing model of sleep regulation postulates that sleep is under the control of two fundamental processes, circadian and homeostatic (1). The circadian process directs the timing of virtually all 24-h behavioral, physiological, and molecular processes, including sleep and wakefulness (2). The sleep homeostatic process regulates the propensity for sleep based on the amount of prior wakefulness; the organism will attempt to regain or compensate for the resource (i.e., sleep) that was previously depleted. Electroencephalogram (EEG) slow-wave activity, also termed nonrapid eye movement (NREM) delta (0.5–4 Hz) power, has been used as the main quantitative operational measure of sleep homeostasis and is commonly equated with sleep intensity or sleep depth (3). Many in vivo studies have shown that, in rodents, acute (e.g., 6- to 24-h) total sleep deprivation (TSD) leads to an immediate compensatory increase in NREM delta power (4–7). In addition, animals usually exhibit a positive rebound in NREM and rapid eye movement (REM) sleep time during the recovery opportunity (4–7). The response to acute TSD has served as a major phenotype for investigations into the physiological and molecular mechanisms that underlie sleep homeostatic regulation.
In contrast, rat studies by Rechtschaffen et al. (6) have shown that the compensatory sleep response to acute TSD does not generalize to longer durations of sleep loss. For example, after 48–96 h of continuous TSD, rats exhibit a large REM rebound but fail to generate any positive rebound in EEG NREM delta power, and NREM sleep time is actually decreased to below baseline (BL) levels, indicating that they regain none of what was lost in these two sleep parameters (6). These data provide evidence that the sleep homeostatic process may be fundamentally different between acute and chronic TSD conditions.
Interestingly, recent studies in humans also indicate that the sleep-recovery process may be altered during conditions of chronic partial sleep loss. In one clinical study, in which healthy young adults were restricted to 4, 6, or 8 h of sleep over 14 consecutive days, there was no indication that cumulative sleep loss over days was compensated by increases in either sleep time or NREM EEG delta power during the daily sleep opportunities (8). In addition, self reports of subjective sleepiness appeared to undergo adaptation and did not increase in severity after the second or third day of sleep restriction. Another study using 3, 5, or 7 h of sleep restriction for 7 consecutive days in healthy young adults showed that, despite an accumulating sleep debt, there was no change in sleep–wake patterns across sleep restriction days or during a recovery opportunity (9). One postulate for these findings is that once some core sleep need is achieved, possibly as little as 3–4 h per night, additional sleep is dispensable and fulfills no pertinent function (10). However, recent experimental studies in humans have shown that chronic partial sleep loss of even 2–3 h per night leads to impairments in cognitive performance, as well as cardiovascular, immune, and endocrine function (8, 9, 11–13), indicating that even mild-to-moderate chronic sleep restriction is not inconsequential.
Despite the fact that chronic partial sleep restriction is a hallmark of life in modern society, few attempts have been made to develop animal models of repeated sleep loss. This is surprising in view of the fact that it was demonstrated 50 years ago that, although rats could tolerate prolonged (10- to 18-wk) partial sleep restriction (sleep allowed for only 4 h per day), such loss led to reduced growth and made the rats extremely irritable and reactive (14). We have identified only one study where sleep homeostasis was specifically assessed in animals exposed to a mild chronic sleep restriction protocol (15). When rats were deprived of sleep during the 12-h light phase for 5 consecutive days, they generated a similar homeostatic response (i.e., increased NREM delta power and sleep amount) during each of the 12-h dark-phase recovery opportunities, suggesting that animals fully compensated to this mild SD protocol on a daily basis.
We have developed a rodent model of repeated sleep restriction (RSR) in which EEG/electromyographic (EMG) activity was recorded continuously for a 24-h BL day, 5 consecutive days of sleep restriction (20 h of SD and 4 h of sleep opportunity per day), and 3 days of full-recovery sleep opportunity. The major and surprising finding to come out of this study was that, after the first day of sleep restriction, animals failed to express a compensatory response in NREM delta power, the primary measure of sleep homeostasis. This lack of rebound, in the context of accumulating sleep debt across days, indicates a change in the homeostatic process to a strategy that is more reflective of an allostatic response to repeated sleep loss.
Results
The data are presented to allow comparisons between 1 BL, 5 sleep-restriction (SD1–SD5), and 3 recovery [recovery day 1 (R1)–R3] days [supporting information (SI) Fig. 4].
Total Sleep Time (TST).
On the BL day, rats slept 10.6 ± 0.4 h across the 24 h, including 8.0 ± 0.4 h during the 20-h time block [zeitgeber time (ZT) 4–24] and 2.6 ± 0.1 h over the 4-h time block (ZT0–4) (Fig. 1A). Significant time effects occurred for TST over the 24-h (F(8, 56) = 152.3, P < 0.001), 20-h (F(8, 56) = 173.8, P < 0.001), and 4-h (F(8, 56) = 2.6, P < 0.05) time blocks. On each day of sleep restriction (SD1–SD5), 24-h TST was significantly decreased compared with the BL day (all post-hoc comparisons, P < 0.001). Similarly, during the 20-h (ZT4–24) sleep-deprivation periods on SD1–SD5, TST was lower than the corresponding 20-h BL period (all post-hoc comparisons, P < 0.001). The average amount of sleep achieved in the wheel during the 20-h sleep-deprivation block was relatively small and ranged from an average of 0.2 ± 0.1 h on SD1 to 1.4 ± 0.4 h on SD5, although there were no significant differences between SD1–SD5 days. During the 4-h (ZT0–4) sleep-opportunity blocks on SD1-SD5, TST showed a small but statistically significant increase on SD1 (P < 0.01) and SD2 (P < 0.05) compared with corresponding 4-h BL levels, whereas no increase in TST was noted on SD3–SD5. Even though there was no change in TST even on the last SD day (SD5), TST over the entire 24 h and the 20-h time block on R1 was significantly increased compared with BL.
Fig. 1.
Sleep time under BL (BL), SD/restriction (SD1–SD5), and recovery (R1–R3) conditions. The amount (h ± SEM) of TST (A), as well as individual NREM (B) and REM (C) sleep states, was determined for each recording day. The recordings were divided into 20-h (open bars, ZT4–24) and 4-h (gray bars, ZT0–4) time blocks, which corresponded to the 20 h of SD and 4 h of restricted sleep opportunity on days SD1–SD5. Sleep amounts were also calculated over the 24-h (filled circles) recording periods. ZT represents time of day (ZT0 = light onset), and ZT0–4 is the first 4 h of the light phase. Asterisks indicate significant differences for 4-, 20-, or 24-h time blocks compared with corresponding BL time intervals (P < 0.05).
NREM Sleep Time.
On the BL day, rats exhibited 8.7 ± 0.4 h of NREM sleep time across the 24-h, including 6.5 ± 0.3 h during the 20-h time block and 2.2 ± 0.1 h over the 4-h time block (Fig. 1b). A significant time effect was detected for NREM sleep time over the 24-h (F(8, 56) = 122.6, P < 0.001), 20-h (F(8, 56) = 125.8, P < 0.001), and 4-h (F(8, 56) = 6.8, P < 0.001) time blocks. On each day of sleep restriction (SD1–SD5), 24-h NREM sleep time was significantly decreased compared with the BL day (all post-hoc comparisons, P < 0.001). During the 20-h (ZT4–24) SD blocks on SD1–SD5, NREM sleep time was dramatically lower than the corresponding 20-h BL period (all post-hoc comparisons, P < 0.001). A small amount of NREM sleep was achieved in the rotating wheel ranging from 0.2 ± 0.1 h on SD1 to 1.3 ± 0.4 h on SD5; however, there were no significant differences between SD1 and SD5. During the 4-h (ZT0–4) sleep-opportunity blocks, there was no significant increase on SD1–SD5 compared with the corresponding 4-h BL time block. In fact, NREM sleep time decreased during the 4-h period on SD4 (P < 0.01) and SD5 (P < 0.01) compared with SD1. During the recovery period, NREM sleep time was significantly increased on R1 during the initial 20-h sleep period (P < 0.001) and nonsignificantly during the 4-h period (P = 0.06) compared with corresponding BL levels. On R2, NREM time was slightly increased during the 4-h interval (P < 0.05) compared with the same 4-h period of BL recording.
REM Sleep Time.
Over the 24-h BL period, rats produced 1.9 ± 0.1 h of REM sleep, comprised of 1.5 ± 0.1 during the 20-h time block and 0.4 ± 0.03 over the 4-h time block (Fig. 1C). A significant time effect was noted for REM sleep time over the 24-h (F(8, 56) = 193.6, P < 0.001), 20-h (F(8, 56) = 311.2, P < 0.001), and 4-h (F(8, 56) = 27.0, P < 0.001) time blocks. On each day of sleep restriction (SD1–SD5), 24-h REM sleep time was significantly reduced compared with the BL day (all post-hoc comparisons, P < 0.001). During the 20-h (ZT4–24) SD block on SD1–SD5, REM sleep time was almost completely eliminated, with only minimal amounts appearing on SD2–SD5. During the 4-h (ZT0–4) sleep opportunity, there was a significant increase in REM sleep time on each sleep restriction day (SD1–SD5) compared with the corresponding BL 4-h time block (all post-hoc comparisons, P < 0.001). The increase in REM sleep time during the 4-h time block on SD5 was continued into the R1 day 20-h time block, where REM sleep was elevated over the corresponding BL 20-h interval (P < 0.001). REM sleep time was reduced during the last 4 h of R1 (P < 0.05), whereas no changes occurred on R2 and R3 compared with the BL condition.
NREM Delta Power.
NREM delta power is commonly used as a quantitative measure of EEG sleep intensity and homeostatic sleep drive. We analyzed NREM delta power during each 20-h (ZT4–24) and 4-h (ZT0–4) time block across BL, SD1–SD5, and R1–R3 days (Fig. 2). During the 20-h wheel deprivation period on SD1–SD5, there were many days when rats achieved no sleep in the wheel or slept only a small amount of time. Furthermore, when a 10-sec epoch was scored as NREM sleep, it normally contained a mixture of wake and NREM EEG signals, because sleep in the wheel was very fragmented. Therefore, the specific measure of NREM delta power could not be accurately determined during the 20-h time block (however, see the alternative analysis in the following paragraph). During the 4-h time blocks, a significant time effect was detected (F(8,56) = 16.4, P < 0.001), such that NREM delta power was significantly increased (+28%) on SD1 compared with the corresponding 4-h BL period (Fig. 2). Thereafter, NREM delta power returned to BL levels and was comparable to BL levels on SD2–SD5. A comparison between BL and R1–R3 days showed that NREM delta power was significantly reduced on R1 (ZT0–4, P < 0.001), R2 (ZT4–24, P < 0.001; ZT0–4, P < 0.05), and R3 (ZT4–24, P < 0.05) compared with the corresponding BL values.
Fig. 2.
EEG NREM delta power. NREM delta power (normalized, % of BL ± SEM) was determined across 20- (ZT4–24) and 4-h (ZT0–4) time blocks on BL (BL), sleep restriction (SD1–SD5), and recovery (R1–R3) days. For the 20-h period, NREM delta power was not calculated on SD1–SD5 because of the minimal amount of NREM sleep time that occurred while animals were in the SD wheels. All significance values represent comparisons to the corresponding 20- or 4-h period of BL (∗, P < 0.05; ∗∗, P < 0.01; ∗∗∗, P < 0.001).
Delta Energy During 20-h Wheel-Deprivation Period.
During the 20-h SD block, the NREM sleep that occurred was in short fragmented bursts (i.e., microsleeps). Therefore, the majority of single 10-sec epochs scored as NREM sleep also contained a portion of wakefulness (i.e., mixed wake–NREM epochs). This pattern would lead to an overestimation of NREM delta power in wakefulness and an underestimation of NREM delta power in NREM sleep. To determine the amount of delta activity achieved in the wheel, we determined the cumulative amount of delta energy (μV2) over the entire 20-h block, regardless of sleep–wake state. This measurement was used to indicate whether animals were compensating for lost sleep in the wheel by increasing or not increasing the amount of delta activity produced in the wheel. Delta energy showed no significant difference between BL, SD1–SD5, and R1–R3 days (F(8,56) = 0.70, P = 0.68) (SI Table 2). These data indicate that, even though animals lost a significant amount of sleep in the wheel, they did not compensate by increasing delta energy above BL levels.
BL vs. Recovery.
In addition to examining sleep and wake during the 20- and 4-h time blocks, to more fully understand recovery sleep after 5 days of RSR, we compared NREM sleep time, NREM delta power, and REM sleep time over 2-h intervals for the 3 recovery days to the pattern during BL sleep. In Fig. 3, the BL and R1–R3 recordings are divided into 2-h intervals beginning at light onset. It should be noted that hours 0–4 on the first full recovery day (Fig. 3) are the same as the 4-h sleep opportunity on SD5 (Fig. 1), the last day of sleep restriction. On the first recovery day, there was a trend for decreased NREM sleep time in the first 6 h of recovery (ZT0–6), followed by a significant increase in NREM sleep time in hours 3–8 of the dark period (ZT15–20) compared with corresponding BL levels (condition main effect, F(1, 7) = 22.4, P < 0.01; condition × time interaction, F(11, 77) = 4.9, P < 0.001) (Fig. 3A). On R2, NREM sleep time was significantly increased during the first 2 h of the light phase (ZT0–2) and during hours 3–6 of the dark phase (ZT15–18) (condition main effect, F(1, 7) = 8.2, P < 0.05; condition × time interaction, F(11, 77) = 2.8, P < 0.01). On R3, no differences in NREM sleep time were observed between BL and recovery conditions.
Fig. 3.
BL vs. recovery sleep. (A) NREM sleep amount (minutes ± SEM), (B) EEG NREM delta power (normalized, % of 24-h BL± SEM), and (C) REM sleep time (minutes ± SEM) are depicted for the 24-h BL (open circles, BL) and the 3 recovery days (dark circles, R1–R3) in 2-h intervals. The recovery data were taken immediately after the last 20-h SD period on SD5 and therefore begin at light onset (ZT0). Note that the BL distribution is triple-plotted to make comparisons with each recovery day. The 12:12 light:dark cycle is indicated at the bottom (open bar, light phase, dark bar, dark phase). Separate repeated-measure ANOVAs were used to compare BL vs. recovery on each day, and post-hoc comparisons were used to identify differences between particular 2-h time intervals. Significance values were set at P < 0.05.
Despite the 5 days of prior sleep restriction, the homeostatic drive for sleep, as measured by NREM delta power, was increased only during the first 2 h of the R1 recovery opportunity (condition × time interaction, F(11, 77) = 2.4, P < 0.01) (Fig. 3B). Thereafter, no indication of a positive rebound occurred during any of the 3 recovery days. Interestingly, during the dark phase of R1 and the light phases of R2 (condition main effect, F(1, 7) = 24.1, P < 0.01; condition × time interaction, F(11, 77) = 7.6, P < 0.001), and R3 (condition main effect, F(1, 7) = 7.7, P < 0.05; condition × time interaction, F(11, 77) = 3.1, P < 0.01), NREM delta power was significantly decreased compared with corresponding BL levels, indicative of a negative rebound.
A clear increase in REM sleep time occurred during most hours of R1 compared with corresponding BL levels (condition main effect, F(1,7) = 112.3, P < 0.001; condition × time interaction, F(11, 77) = 2.3, P < 0.05) (Fig. 3C). A combination of positive and negative rebounds occurred on R2 (condition × time interaction, F(11,77) = 3.0, P < 0.01). On R3, there were no differences between BL and R conditions.
Cumulative Sleep Loss and Recovery.
The amount of total sleep loss during the ZT4–24 block was determined for each sleep restriction day (SD1–SD5) and accumulated over the 5 days (SI Fig. 5). Animals lost a mean of 35.8 ± 2.8 h of sleep over the five 20-h blocks of SD. Similarly, the amount of sleep gained over BL levels was determined for each 4-h sleep opportunity (SD1–SD5) (SI Fig. 5). Animals accumulated 0.8 ± 0.4 h of sleep over BL levels during the five 4-h sleep opportunities, even though there was a total potential net recovery of 7.0 ± 0.5 h over BL levels across the five 4-h time blocks. The net result was an average loss of 35.0 h of sleep over the 5-day (SD1–SD5) period. Yet, by the end of R3, rats had recovered only a total of 2.6 h of sleep (vs. BL), consisting of 2.3 h during the ZT4–24 time block and 0.3 h over the ZT0–4 time blocks. This represented only a small portion of the potential net recovery for the combined 20- and 4-h recovery opportunities across R1–R3 (40.2 ± 1.2 h). At the end of R3, animals had a remaining sleep debt of 32.4 h. The cumulative sleep loss and recovery values for individual NREM and REM sleep states are presented in Table 1.
Table 1.
Cumulative sleep loss and recovery during sleep restriction and recovery days
| Sleep time | Sleep loss/gain, ZT4–24 | Sleep loss/gain, ZT0–4 | Net sleep loss/gain |
|---|---|---|---|
| Total | |||
| SD1–SD5 | −35.8 ± 2.4 | +0.8 ± 0.4 | −35.0 ± 2.5 |
| R1–R3 | +2.3 ± 0.4 | +0.2 ± 0.3 | +2.6 ± 0.5 |
| SD1–R3 | −33.4 ± 2.6 | +1.0 ± 0.7 | −32.4 ± 2.6 |
| NREM | |||
| SD1–SD5 | −28.3 ± 2.2 | −0.4 ± 0.3 | −28.7 ± 2.3 |
| R1–R3 | +1.3 ± 0.4 | +0.4 ± 0.3 | +1.7 ± 0.5 |
| SD1–R3 | −27.0 ± 2.4 | +0.0 ± 0.5 | −27.0 ± 2.5 |
| REM | |||
| SD1–SD5 | −7.5 ± 0.5 | +1.2 ± 0.2 | −6.3 ± 0.3 |
| R1–R3 | +1.1 ± 0.2 | −0.2 ± 0.1 | +0.9 ± 0.2 |
| SD1–R3 | −6.5 ± 0.6 | +1.0 ± 0.3 | −5.4 ± 0.4 |
The amount (hours ± SEM) of sleep loss (−) and sleep gain (+) was determined for 20-h (ZT4–24), 4-h (ZT0–4), and 24-h (net sleep loss/gain) time blocks over the 5 days of sleep restriction (SD1–SD5), the 3 days of full recovery (R1–R3), and the total 8-day protocol (SD1–R3). Sleep loss during the 20-h wheel deprivation was calculated based on the average amount of sleep during the corresponding 20-h BL period minus any sleep that occurred in the wheel. Sleep gain was calculated as the amount of sleep during the 20- or 4-h time block that reached above the corresponding BL level.
Discussion
In this study, we developed an animal model of RSR in which rats were kept awake for 20 h and given a 4-h sleep opportunity each day for 5 consecutive days. By allowing a 4-h sleep window each day, animals had the opportunity to generate a compensatory response to the prior sleep loss. However, this window was not long enough to completely regain all of the sleep that was lost during the 20-h SD period; therefore, the animals continued to accumulate a sleep debt each day. The protocol was designed to investigate the sleep homeostatic response, both in terms of EEG sleep intensity (i.e., NREM delta power) and sleep amount, over a 5-day period of accumulating sleep debt. The most important and surprising result was that, as sleep loss accrued over repetitive days of sleep restriction, animals failed to sustain a compensatory response in NREM sleep intensity during their sleep opportunities. These results suggest that the sleep homeostatic response to acute TSD (e.g., 6–24 h) does not generalize to more chronic or cumulative sleep-loss conditions. We propose an explanation for the fundamentally different responses between acute and chronic sleep loss, a model of allostasis after RSR.
After the first block of 20-h SD (SD1), rats generated a positive rebound (i.e., increase over BL levels) in both EEG NREM delta power and REM sleep time during the 4-h sleep opportunity, compared with the corresponding 4-h BL interval; these increases are indicative of an acute homeostatic response (Figs. 1 and 2). The compensatory increase in NREM sleep intensity is consistent with previous in vivo data from acute (6- to 24-h) TSD studies in rats (4–6). NREM delta power is normally the first component of the compensatory sleep response to be expressed after acute TSD, indicating that physiological processes linked to EEG delta wave generation are vital for the recuperative response to sleep loss.
The most remarkable finding in this study was that, during the 4-h recovery opportunities on SD2–SD5, animals failed to exhibit the same positive rebound in EEG NREM delta power that appeared on SD1, despite having accrued an even greater amount of sleep debt each day. In fact, during the 4-h recovery periods on SD2–SD5, NREM sleep intensity returned to original BL levels. These data demonstrate a clear change in the homeostatic sleep response in the context of acute sleep loss vs. RSR conditions.
One possible reason for the loss in sleep homeostatic drive was that sleep drive was dissipated while the animals were being sleep-deprived, either through microsleeps or through increased delta activity in wakefulness. We determined that the amount of delta activity (i.e., delta energy) that accrued across the 20-h (ZT4–24) SD procedure was similar to corresponding BL levels (SI Table 2). Therefore, animals did not compensate for the significant loss of sleep by increasing total delta energy across wakefulness and sleep during the SD procedure. This finding indicates the reduction in NREM delta power during the 4-h sleep opportunities was not accounted for by a compensatory increase in cumulative delta activity during the course of SD.
Another remarkable finding in this study was that, despite the accumulated 35 h of sleep loss across SD1–SD5, animals failed to recover any amount of NREM sleep time during the 4-h sleep opportunities and did not increase the magnitude of REM rebound across days (Fig. 1). In fact, on SD4 and SD5, NREM sleep time was significantly lower compared with corresponding BL levels, indicative of a negative rebound. In total, animals had the capacity to regain ≈7 h of NREM and REM sleep time over corresponding BL levels between SD1 and SD5; however, they averaged only 0.8 h of sleep rebound (Table 1 and SI Fig. 5). Therefore, animals failed to use all of the time that was available to them to sleep during the 4-h time blocks. One explanation for the lack of a positive NREM rebound could be that the 4-h sleep opportunity was not long enough for an increase in NREM sleep amount to be expressed. That is, the animals exhibited a selective preference to increase REM sleep rather than NREM sleep time. Previous studies in rats have shown that after 24 h of TSD, a pronounced rebound in NREM sleep time can be delayed by many hours after the termination of SD (16).
After the SD block on SD5, animals were given 3 full days of an ad-lib recovery opportunity to detect a possible delay in the recovery pattern to the previous days of sleep loss (Fig. 3). After a brief increase in NREM delta power during only the first 2 h of R1, levels quickly returned to BL levels and showed a dramatic and sustained negative rebound during the dark phase on R1 and the light phases of R2 and R3. Therefore, even during an extended recovery opportunity, animals showed virtually no tendency to gain back lost sleep by increasing sleep intensity. NREM sleep time was increased during the dark phase on R1 and R2; however, the amount of sleep regained hardly approached the amount that was previously lost and sleep intensity was no greater than BL levels (Table 1). Because the rebound in NREM sleep time during the recovery days was small and showed no increase in EEG sleep intensity, it is unlikely that the negative rebound in NREM delta power could be accounted for by the increased NREM sleep time. Therefore, we conclude that the negative rebound in NREM delta power is not a function of the homeostatic process but is related to another regulatory process, as described later in Discussion. The rebound in REM sleep was primarily restricted to R1 and accounted for only a small proportion of REM sleep that was lost during the deprivation episodes. Therefore, even during the full recovery sleep opportunities on R1–R3, animals used only a small portion of the time that was available on the recovery days to regain sleep or pay off their accumulated sleep debt.
The two-process model of sleep regulation has been used to predict the homeostatic response to SD, using NREM delta power as a quantitative measure of sleep homeostasis (1, 17). The model predicts that, after prolonged or repeated SD, NREM delta power will reach a saturating exponential or a “peak” level that cannot be surpassed, even in the face of additional sleep loss. Our results are strikingly different from this prediction, because on SD2–SD5, NREM delta power did not remain at a saturated level but dissipated to pre-deprivation BL levels (Fig. 2). Furthermore, on the full recovery days (R1–R3), NREM delta power was predominantly maintained at or below original BL levels (Fig. 3). Therefore, our data suggest that during the course of RSR, sleep falls under the regulation of a process other than homeostatic regulation. The rest of this discussion will develop a rationale for what this alternative process may be.
Clinical studies have shown that chronic partial sleep loss results in significant alterations in energy metabolism and cardiovascular function. For example, sleep restriction in young healthy subjects to 4 h per night for 5 consecutive nights results in symptoms of early-stage diabetes (13). In addition, experimental sleep restriction has been associated with increased risk factors for cardiovascular disease, such as high levels of C-reactive protein (11). We have recently used the RSR paradigm to demonstrate that rats allowed to sleep for only 4 h per day for 8 consecutive days have increased basal corticosterone levels and develop pronounced changes in the reactivity of the hypothalamo-pituitary-adrenal axis to stress (18). RSR and other forms of SD have also been shown to alter regulation of corticosterone (18–20) and proinflammatory cytokine levels (21, 22), elevate markers of oxidative stress (23), and promote neurodegenerative processes in the hippocampus (24, 25).
Taken together, data from human and animal studies indicate that RSR results in two notable consequences, (i) a change in the sleep response to cumulative sleep loss and (ii) changes in the regulation of multiple physiological systems. Although most studies have examined specific physiological pathways affected by SD, few models to integrate the multiple effects of sleep loss have been available. McEwen (26) has recently proposed that the biological model of allostasis and allostatic load may be used to explain the deleterious effects of sleep loss. The concept of allostasis refers to the maintenance of stability within the organism through change, a process that allows for the integration of physiology and behavior in response to a changing environment (27). Allostasis is mediated primarily by stress responses that, in the short term, lead to coordinated changes in physiological systems that result in adaptive behavior. However, when mediators of allostasis, such as glucocorticosteroids, autonomic nervous system activity, or inflammatory cytokines, are chronically high, an allostatic load or overload will develop that takes the animal out of an adaptive response mode and leads to multiple pathologies (27).
The stress response elicited by SD has long been considered a confounding factor in studies attempting to isolate the specific role of sleep loss itself on any independent variable under investigation. Indeed, RSR is associated with elevations in corticosterone (18–20), sympathetic tone, and cytokine levels (13, 21, 22), important mediators of allostasis and allostatic load. We have used the current RSR model (4-h sleep per day for 5 consecutive days) to demonstrate elevated corticosterone levels on SD1 and SD5, even when blood samples were collected after the 4-h sleep opportunity (unpublished data). Rather than discarding the stress response as an unwanted experimental confound, the allostatic model incorporates stress as a critical component of the physiological state of SD (26). In this framework, the condition of TSD or RSR represents a stress that adds to the allostatic load on various physiological systems and results in nonadaptive responses and adverse health consequences (e.g., metabolic, cardiovascular, immune, and neurocognitive impairments).
Our finding that RSR results in a change in the homeostatic sleep response raises the intriguing possibility that the sleep–wake regulatory system itself is significantly impacted by the allostatic load of cumulative sleep loss. That is, the allostatic load resulting from RSR feeds back onto the sleep–wake system, in turn changing the acute compensatory sleep response into an allostatic response. Specifically, we interpret the loss of NREM delta power rebound on SD2–SD5, the prolonged negative rebound in NREM delta power during R1–R3, and the reduction in NREM sleep time on SD4–SD5, as signs of allostasis. REM sleep, which exhibited a consistent positive rebound, is possibly less susceptible to allostasis and is able to remain under some degree of homeostatic control around the original set point.
Saper et al. (28) have speculated that the homeostatic and circadian drive for sleep can be overcome for brief periods of time by an allostatic drive when external conditions demand a change in the sleep–wake regulatory system. Such a change might be adaptive for an animal in the wild, because TSD or RSR would be expected to occur only under emergency environmental conditions when a change from normal life events to a survival mode would be necessary. The homeostatic pressure to sleep, along with subsequently falling asleep when an animal must maintain wakefulness under emergency circumstances (e.g., flooding), is of obvious detriment for survival, and thus the need for an allostatic response to repeated sleep loss might be more beneficial for survival. Of course, there could be a limit to the amount and/or duration of sleep loss that is tolerable to meet environmental demands; anything beyond this limit would then lead to nonadaptive physiological changes and negative consequences to the organism. Indeed, it is conceivable that allostasis in the sleep recovery process could itself add to allostatic load in the stress response system, setting up a positive feedback series of events with negative health consequences in organisms partially sleep-restricted for long periods of time. Using the conceptual structure of the allostatic model, many hypotheses can be addressed regarding the relationship between chronic sleep loss and health, including investigations into the physiological, molecular, and genetic mechanisms that link sleep with specific physiological processes and disease states. The growing number of epidemiological and experimental studies demonstrating close reciprocal relationships between sleep and a diverse range of disease states (29) points to the importance of developing animal models and conceptual models to investigate these important links.
Methods
Subjects.
Male F344 rats (n = 8, 3 months of age) from the National Institute of Aging colony were used in this study. Animals were housed individually and maintained on a light–dark 12:12 cycle with free access to food and water. Protocols were approved by the Northwestern University Animal Care and Use Committee.
Surgical Procedures.
Rats were anesthetized (ketamine 87 mg/kg and xylazine 13 mg/kg, i.p.) and surgically implanted with EEG and EMG electrodes for sleep–wake recording. EEG electrodes (Small Parts, Miami Lakes, FL) were placed contralaterally on the skull surface (1.0 mm anterior to Bregma/1.0 mm right of the central suture and 1.0 mm posterior to lambda/on the extended line of the central suture). EMG activity was monitored by using stainless steel Teflon-coated wires placed bilaterally in the nuchal muscle in the dorsal neck region. After surgery, animals remained in their home cage for 2 weeks to recover.
Experiment Design.
After recovery, animals were transferred to sleep-recording chambers and connected to a wire tether/commutator system (Plastics One, Roanoke, VA) for the collection of EEG/EMG signals. Each animal was placed in an individual chamber that contained a sleep-recording cage and a SD wheel. The chambers were light-, temperature-, and sound-controlled. A 7-day adaptation period to the recording environment was allowed before the 9-day experimental protocol was performed. On day 1, sleep was recorded for a 24-h BL period beginning 4 h after light onset (ZT4), as depicted in SI Fig. 4. For the next 5 consecutive days (SD1–SD5), animals were sleep-deprived for 20 h (ZT4–24), followed by a restricted 4-h ad lib sleep opportunity. The protocol was designed so that the 4-h blocks of restricted sleep on SD1–SD5 began at light onset (ZT0–4). After the last day of sleep restriction, animals were allowed a 3-day recovery period (R1–R3). EEG/EMG recordings were collected throughout the entire protocol, including the SD blocks and ad lib sleep opportunities.
SD.
Animals were sleep-deprived by placing them in a slowly rotating wheel [(Techniplast USA, Exton, PA) stainless steel, 13.5 inch in diameter, 3.75 inch in width] maintained at a constant speed (1.5 rpm) by a motor. Food and water were freely available. EEG/EMG was continually recorded in the wheel. After each 20-h SD period, animals were quickly placed back into their sleep-recording cage for the 4-h sleep opportunity.
Sleep Data Collection and Analysis.
EEG signals were amplified ×10,000 with high- and low-pass filters set at 1 and 30 Hz, respectively. EMG signals were amplified ×5,000 with high- and low-pass filters set at 3 and 100 Hz. Both signals were then digitized at 102.4 Hz by an analog-to-digital converter (Data Translation, Inc., Marlboro, MA, model DT-01EZ) and stored on a Dell Pentium IV (ABT Electronics, Chicago, IL) computer. Waveforms were collected by using Multisleep (Actimetrics, Evanston, IL), a software system designed for gathering and analyzing rodent sleep data. After data collection, the EEG and EMG signals were reconstituted on a computer screen in 10-sec epochs and visually scored as either wake NREM or REM sleep. For quantitative analysis of the EEG signal in the frequency domain, each 10-sec scored epoch was subjected to fast Fourier transformation. In particular, for epochs of NREM sleep, the EEG power in the delta (1- to 4-Hz) frequency range was calculated. During the 20-h SD blocks and corresponding BL and R periods, total delta energy [i.e., summed delta power (μV2) across all epochs] was determined. Epochs containing artifact were eliminated from power spectral analysis.
Postscoring analysis was performed by using SleepReport (Actimetrics) for the determination of sleep-structure parameters. Depending on the particular analysis, wake, NREM, and REM sleep amounts, as well as NREM delta power, were determined in 2-, 4-, 20-, or 24-h intervals. For statistical comparisons of sleep–wake parameters across BL, SD1–SD5, and R1–R3 conditions, a repeated-measures analysis of variance (Statistica, StatSoft, Tulsa, OK) was used. Post-hoc comparisons were made by using the least standard difference test, when indicated. A value of P < 0.05 was considered significant for all comparisons.
Supplementary Material
Acknowledgments
This research was supported by National Institutes of Health Grants P01AG11412 and R01HL075029.
Abbreviations
- REM
rapid eye movement
- NREM
non-REM
- TSD
total sleep deprivation
- RSR
repeated sleep restriction
- EEG
electroencephalogram
- EMG
electromyographic
- TST
total sleep time
- ZT
zeitgeber time
- BL
baseline
- SD
sleep deprivation
- Rn
recovery day n.
Footnotes
The authors declare no conflict of interest.
This article is a PNAS Direct Submission.
This article contains supporting information online at www.pnas.org/cgi/content/full/0610351104/DC1.
References
- 1.Daan S, Beersma GM, Borbely AA. Am J Physiol. 1984;246:R161–R178. doi: 10.1152/ajpregu.1984.246.2.R161. [DOI] [PubMed] [Google Scholar]
- 2.Rosenwasser AM, Turek FW. In: Principles and Practices of Sleep Medicine. Kryger MH, Roth T, Dement W, editors. New York: Saunders; 2005. pp. 351–362. [Google Scholar]
- 3.Steriade M. In: Principles and Practice of Sleep Medicine. Kryger MH, Roth T, Dement WC, editors. Philidelphia, PA: Elsevier; 2005. pp. 101–119. [Google Scholar]
- 4.Tobler I, Borbely AA. Behav Brain Res. 1990;36:73–78. doi: 10.1016/0166-4328(90)90161-7. [DOI] [PubMed] [Google Scholar]
- 5.Franken P, Tobler I, Borbely AA. Physiol Behav. 1993;54:885–894. doi: 10.1016/0031-9384(93)90297-s. [DOI] [PubMed] [Google Scholar]
- 6.Rechtschaffen A, Bergmann BM, Gilliland MA, Bauer K. Sleep. 1999;22:11–31. doi: 10.1093/sleep/22.1.11. [DOI] [PubMed] [Google Scholar]
- 7.Laposky A, Easton A, Dugovic C, Walliser J, Bradfield CA, Turek FW. Sleep. 2005;28:395–409. doi: 10.1093/sleep/28.4.395. [DOI] [PubMed] [Google Scholar]
- 8.Van Dongen HP, Maislin G, Mullington JM, Dinges DF. Sleep. 2003;26:117–126. doi: 10.1093/sleep/26.2.117. [DOI] [PubMed] [Google Scholar]
- 9.Belenky G, Wesensten NJ, Thorne DR, Thomas ML, Sing HC, Redmond DP, Russo MB, Balkin TJ. J Sleep Res. 2003;12:1–12. doi: 10.1046/j.1365-2869.2003.00337.x. [DOI] [PubMed] [Google Scholar]
- 10.Horne J. Why We Sleep. New York: Oxford Univ Press; 1988. p. 319. [Google Scholar]
- 11.Meier-Ewert HK, Ridker PM, Rifai N, Regan MM, Price NJ, Dinges DF, Mullington JM. J Am Coll Cardiol. 2004;43:678–683. doi: 10.1016/j.jacc.2003.07.050. [DOI] [PubMed] [Google Scholar]
- 12.Spiegel K, Sheridan JF, Van Cauter E. J Am Med Assoc. 2002;288:1471–1472. doi: 10.1001/jama.288.12.1471-a. [DOI] [PubMed] [Google Scholar]
- 13.Spiegel K, Leproult R, Van Cauter E. Lancet. 1999;354:1435–1439. doi: 10.1016/S0140-6736(99)01376-8. [DOI] [PubMed] [Google Scholar]
- 14.Licklider J, Bunch M. J Comp Psychol. 1946;39:339–350. doi: 10.1037/h0060623. [DOI] [PubMed] [Google Scholar]
- 15.Lancel M, Kerkhof GA. Physiol Behav. 1989;45:289–297. doi: 10.1016/0031-9384(89)90130-3. [DOI] [PubMed] [Google Scholar]
- 16.Schwierin B, Borbely AA, Tobler I. Neurosci Lett. 1999;261:61–64. doi: 10.1016/s0304-3940(98)01006-4. [DOI] [PubMed] [Google Scholar]
- 17.Brunner DP, Dijk DJ, Borbely AA. Sleep. 1993;16:100–113. doi: 10.1093/sleep/16.2.100. [DOI] [PubMed] [Google Scholar]
- 18.Meerlo P, Koehl M, van der Borght K, Turek FW. J Neuroendocrinol. 2002;5:397–402. doi: 10.1046/j.0007-1331.2002.00790.x. [DOI] [PubMed] [Google Scholar]
- 19.Andersen ML, Martins PJ, D'Almeida V, Bignotto M, Tufik S. J Sleep Res. 2005;14:83–90. doi: 10.1111/j.1365-2869.2004.00428.x. [DOI] [PubMed] [Google Scholar]
- 20.Sgoifo A, Buwalda B, Roos M, Costoli T, Merati G, Meerlo P. Psychoneuroendocrinology. 2006;31:197–208. doi: 10.1016/j.psyneuen.2005.06.009. [DOI] [PubMed] [Google Scholar]
- 21.Vgontzas AN, Zoumakis E, Bixler EO, Lin HM, Follett H, Kales A, Chrousos GP. J Clin Endocrinol Metab. 2004;89:2119–2126. doi: 10.1210/jc.2003-031562. [DOI] [PubMed] [Google Scholar]
- 22.Everson CA. Am J Physiol. 2005;289:R1054–R1063. doi: 10.1152/ajpregu.00021.2005. [DOI] [PubMed] [Google Scholar]
- 23.Silva RH, Abilio VC, Takatsu AL, Kameda SR, Grassl C, Chehin AB, Medrano WA, Calzavara MB, Registro S, Andersen ML, et al. Neuropharmacology. 2004;46:895–903. doi: 10.1016/j.neuropharm.2003.11.032. [DOI] [PubMed] [Google Scholar]
- 24.Tung A, Takase L, Fornal C, Jacobs B. Neuroscience. 2005;134:721–723. doi: 10.1016/j.neuroscience.2005.06.008. [DOI] [PubMed] [Google Scholar]
- 25.Hairston IS, Little MT, Scanlon MD, Barakat MT, Palmer TD, Sapolsky RM, Heller HC. J Neurophysiol. 2005;94:4224–4233. doi: 10.1152/jn.00218.2005. [DOI] [PubMed] [Google Scholar]
- 26.McEwen BS. Metabolism. 2006;55:S20–S23. doi: 10.1016/j.metabol.2006.07.008. [DOI] [PubMed] [Google Scholar]
- 27.McEwen BS, Wingfield JC. Horm Behav. 2003;43:2–15. doi: 10.1016/s0018-506x(02)00024-7. [DOI] [PubMed] [Google Scholar]
- 28.Saper CB, Scammell TE, Lu J. Nature. 2005;437:1257–1263. doi: 10.1038/nature04284. [DOI] [PubMed] [Google Scholar]
- 29.Zee PC, Turek FW. Arch Intern Med. 2006;166:1686–1688. doi: 10.1001/archinte.166.16.1686. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.



